About
Jonny Hsu holds a degree in biochemistry from the University of Waterloo and was an early-stage employee at Valence Discovery, where he led product and strategy until the company's acquisition by Recursion in 2023. He subsequently joined Recursion's AI research division, Valence Labs, and is now developing foundation models for RNA therapeutics.
Jonny @hsu_jonny
How much better could AI agents get at scientific discovery if they could search in biological embedding space instead of text? Over the past few months, we’ve been building Ladon, our bulk transcriptomics foundation model. As an experiment, we embedded over 1 million public https://t.co/onfHaVW5rv
Jul 27, 2026 · ♥ 250 · ⇄ 34
Jonny @hsu_jonny
I'm headed to #ASCO2026 in a few days! Last week, we released a blog covering a few topics that we've been thinking deeply about @blankbio_ : 1. Billion-dollar clinical trial decisions are made using crude approximations of biology. 2. Many good drugs fail because their effect
May 26, 2026 · ♥ 8
Jonny @hsu_jonny
Thanks to Huanjia Zhang for covering our story today in @GenomeWeb! The article highlights our seed round, our strategic collaboration with @PacBio, and our work in building RNA foundation models to accelerate clinical trials https://t.co/7k7o91yO0U
May 19, 2026 · ♥ 9 · ⇄ 1
Founder at Blank BioYC S25
Intro paths
Jonny went through Y Combinator (Summer 2025) — any YC alum in your network can reach them through the YC community.
Their group partner at YC was Ankit Gupta, General Partner at Y Combinator — the partner who ran Blank Bio's batch and knows the company first-hand. YC profile ↗
In turn, Jonny can intro founders to Blank Bio's investors below.
Blank Bio's investors · 6
Co-founders at Blank Bio
